{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:15:30Z","timestamp":1787026530399,"version":"build-2736575974"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["407702\/2012-1"],"award-info":[{"award-number":["407702\/2012-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["402010\/2012-4"],"award-info":[{"award-number":["402010\/2012-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-003478-13"],"award-info":[{"award-number":["APQ-003478-13"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02488","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:22:29Z","timestamp":1541118149000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against Schistosoma mansoni Reinfection in Mice"],"prefix":"10.3389","volume":"9","author":[{"given":"Clarice Carvalho","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neusa","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma Patr\u00edcia de Oliveira Santos","family":"Bernardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Moreira","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Costa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Toscano","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1016\/j.vaccine.2016.03.112","article-title":"Human anthelminthic vaccines: rationale and challenges","volume":"34","author":"Hotez","year":"2016","journal-title":"Vaccine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Global","year":"2015","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fimmu.2015.00095","article-title":"Eliminating schistosomes through vaccination: what are the best immune weapons?","volume":"6","author":"Fonseca","year":"2015","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1365-2249.2006.03081.x","article-title":"Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies","volume":"144","author":"Cardoso","year":"2006","journal-title":"Clin Exp Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1371\/journal.pntd.0000308","article-title":"Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection","volume":"2","author":"Cardoso","year":"2008","journal-title":"PLoS Negl Trop Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/pim.12118","article-title":"A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice","volume":"36","author":"Pinheiro","year":"2014","journal-title":"Parasite Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.exppara.2014.07.010","article-title":"Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection","volume":"145","author":"Ewaisha","year":"2014","journal-title":"Exp Parasitol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0003537","DOI":"10.1371\/journal.pntd.0003537","article-title":"Sm29, but not Sm22","volume":"9","author":"Alves","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/s0264-410x(02)00168-8","article-title":"The global impact of vaccines containing aluminium adjuvants","volume":"20","author":"Clements","year":"2002","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4049\/jimmunol.181.1.17","article-title":"Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1084\/jem.20071087","article-title":"Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells","volume":"205","author":"Kool","year":"2008","journal-title":"J Exp Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4049\/jimmunol.1600420","article-title":"The Syk-NFAT-IL-2 pathway in dendritic cells is required for optimal sterile immunity elicited by alum adjuvants","volume":"198","author":"Khameneh","year":"2017","journal-title":"J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0008-8749(89)90011-7","article-title":"Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses","volume":"121","author":"Grun","year":"1989","journal-title":"Cell Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/eji.1830260915","article-title":"In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant but continues to induce T helper 2 cytokine production","volume":"26","author":"Brewer","year":"1996","journal-title":"Eur J Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"E00492","DOI":"10.1128\/mBio.00492-17","article-title":"Rationally designed TLR4 ligands for vaccine adjuvant discovery","volume":"8","author":"Gregg","year":"2017","journal-title":"mBio"},{"key":"B17","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.1016\/S0021-9258(18)33836-5","article-title":"Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium","volume":"257","author":"Qureshi","year":"1982","journal-title":"J Biol Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1128\/IAI.00022-11","article-title":"The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection","volume":"79","author":"Romero","year":"2011","journal-title":"Infect Immun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1128\/IAI.71.5.2498-2507.2003","article-title":"Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A","volume":"71","author":"Martin","year":"2003","journal-title":"Infect Immun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e63344","DOI":"10.1371\/journal.pone.0063344","article-title":"Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice","volume":"8","author":"Todoroff","year":"2013","journal-title":"PLoS ONE"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.imbio.2013.05.006","article-title":"Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB\/c mice","volume":"218","author":"Hu","year":"2013","journal-title":"Immunobiology"},{"key":"B23","first-page":"589","article-title":"T\u00e9cnica de perfus\u00e3o para colheita de Schistosoma mansoni em cobaias experimentalmente infestadas","volume":"8","author":"Pellegrino","year":"1956","journal-title":"Rev Bras Malariol Doen\u00e7as Trop."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0125075","DOI":"10.1371\/journal.pone.0125075","article-title":"DNA Vaccine encoding the chimeric form of Schistosoma mansoni Sm-TSP2 and Sm29 confers partial protection against challenge infection","volume":"10","author":"Gon\u00e7alves","year":"2015","journal-title":"PLoS ONE"},{"key":"B25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jconrel.2018.02.004","article-title":"The use of gold nanorods as a new vaccine platform against schistosomiasis","volume":"275","author":"Assis","year":"2018","journal-title":"J Control Release"},{"key":"B26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1645\/14-664","article-title":"Parasitological, Pathological, and Immunological Parameters Associated with Schistosoma mansoni Infection and Reinfection in BALB\/c AND C57BL\/6 Mice","volume":"102","author":"Alves","year":"2016","journal-title":"J Parasitol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.vaccine.2011.01.040","article-title":"Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models","volume":"29","author":"Torben","year":"2011","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/pim.12091","article-title":"Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization","volume":"36","author":"Melo","year":"2014","journal-title":"Parasite Immunol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.162.1.345","article-title":"Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms","volume":"162","author":"Jankovic","year":"1999","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0005306","DOI":"10.1371\/journal.pntd.0005306","article-title":"Schistosoma mansoni infection of mice, rats and humans elicits a strong antibody response to a limited number of reduction-sensitive epitopes on five major tegumental membrane proteins","volume":"11","author":"Krautz-Peterson","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1004033","DOI":"10.1371\/journal.ppat.1004033","article-title":"An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas","volume":"10","author":"Gaze","year":"2014","journal-title":"PLoS Pathog."},{"key":"B34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jaci.2012.04.027","article-title":"Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths","volume":"130","author":"Diemert","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/srep00472","article-title":"Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobium","volume":"2","author":"Nausch","year":"2012","journal-title":"Sci Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13071-016-1369-9","article-title":"Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?","volume":"9","author":"Wilson","year":"2016","journal-title":"Parasit Vectors"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02488\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T13:51:52Z","timestamp":1694008312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02488\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2018.02488"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02488","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]},"article-number":"2488"}}